Regulus names Timothy M. Wright as R&D officer
Dr. Wright joins Regulus from California Institute for Biomedical Research (Calibr), a not-for-profit translational research institute, where he was Executive Vice President of Translational Sciences since February 2015.
Prior to Calibr, Dr. Wright held a variety of positions with increasing levels of responsibility over an 11-year period at Novartis Pharma most recently as Global Head of Development.
Prior to Novartis, Dr. Wright spent three years at Pfizer holding leadership positions in Discovery and Clinical Sciences, leading translational research efforts and clinical trials for numerous programs across several therapeutic areas.
Dr. Wright was trained as a physician-scientist at Johns Hopkins and had an accomplished academic career at both Johns Hopkins and the University of Pittsburgh before moving to pharma.
He also serves as a key scientific advisor to several organizations, including the Bill & Melinda Gates Foundation. ■
What to read next
LATEST MOVES FROM California
- Reed's appoints Stefan Freeman as interim CEO
- Heron Therapeutics appoints Robert E. Hoffman as CFO
- Penumbra appoints Bridget O'Rourke to board
- Adverum Biotechnologies adds Richard N. Spivey to board
- Lombard Medical appoints Kurt Lemvigh as CEO
More inside POST
Leaders who can read the crowd do better Leadership
Harley-Davidson Q1 profit drops 24% Earnings